Anthem Shares Jump On Raised FY22 Outlook Boosted By Better Than Expected Q1 Results

  • Anthem Inc ANTM has reported Q1 FY22 adjusted EPS of $8.25, up 17.7% Y/Y, beating the consensus of $7.81.
  • Operating revenue rose 18% to $37.9 billion, slightly beating the expectations of $37.42 billion, driven by higher premium revenue due to growth in Medicaid & Medicare, MMM & Paramount acquisitions, higher premium rates, and pharmacy product revenue related to IngenioRx.
  • The benefit expense ratio was 86.1%, increasing 50 basis points versus the prior-year quarter. 
  • Operating cash flow was $2.5 billion, or 1.4x net income, increasing $36 million when compared year-over-year.
  • Medical enrollment increased 7.5% Y/Y to 46.8 million members. 
  • Medical enrollment increased by 1.4 million lives, driven by organic growth in Commercial fee-based business, the acquisition of Paramount Advantage's Medicaid members in Ohio, and growth in Individual Medicare Advantage enrollment.
  • On April 19, 2022, the company's board declared a second-quarter 2022 dividend of $1.28 per share, payable on June 24, 2022, to shareholders of record on June 10, 2022.
  • FY22 Outlook: Anthem expects FY22 adjusted EPS of more than $28.40 versus prior guidance of $28.25.
  • Price Action: ANTM shares are up 3.13% at $533.21 during the premarket session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Posted In: EarningsNewsGuidanceDividendsHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!